Cui, J., Li, W., Cao, J., Lu, Y., Quan, M., Wu, J., Zhang, M., Li, D., Qu, X., Li, Z., Wang, L. (2025). ALTER-PA001: A multicenter, randomized study of anlotinib and benmelstobart in combination with AG chemotherapy vs. AG as first-line treatment for metastatic pancreatic cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps4228